Testing Companies Pay Almost $1.75 Million to Settle Allegations They Billed Court-Ordered Drug Tests to Healthcare Programs
Two drug testing businesses have agreed to collectively pay nearly $1.75 million to settle allegations they improperly billed non-medical tests to Medicare and Medicaid.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.